The discovery of ChgA as an T1D self-antigen is related to its ability to stimulate the diabetogenic BDC-2.5 CD4+ T cell clone, whose cognate antigen went unrecognized for many years (57). This evidence concerns the gene CD4 and type 1 diabetes mellitus.